Assoz. Prof. Mag. Dr. Anna Weinzinger, Privatdoz.
T: +43-1-4277-55311
41 - 60 out of 72
Saxena P, Linder T, Stary-Weinzinger A, IJzerman AP, Timin E, Ecker GF et al. Insights into Molecular Basis of hERG Inhibition by Studying a Library of Dofetilide Derivatives. Biophysical Journal. 2014 Jan 28;106(2):138a. doi: 10.1016/j.bpj.2013.11.806

Ke S, Timin E, Weinzinger A. Different inward and outward conduction mechanisms in NaVMs suggested by molecular dynamics simulations. PLoS Computational Biology. 2014;10(7):e1003746. doi: 10.1371/journal.pcbi.1003746

Lukacs P, Gawali V, Cervenka R, Ke S, Rubi L, Zarrabi T et al. Exploring the structure of the voltage-gated Na+ channel by an engineered drug access pathway to the receptor site for local anesthetics. Journal of Biological Chemistry. 2014;289(31):21770-21781. doi: 10.1074/jbc.M113.541763

Saxena P, Linder T, Weinzinger A, Timin E, Ecker GF, Hering S. Refined Molecular Model for Dofetilide-Herg Channel interaction. Indian Journal of Pharmacology. 2013 Dec;45:S32-S32.

van der Heyden MAG, Stary-Weinzinger A, Sanchez-Chapula JA. Inhibition of cardiac inward rectifier currents by cationic amphiphilic drugs. Current molecular medicine. 2013 Sept;13(8):1284-98.

Takanari H, Nalos L, Stary-Weinzinger A, de Git KCG, Varkevisser R, Linder T et al. Efficient and specific cardiac IK₁ inhibition by a new pentamidine analogue. Cardiovascular Research. 2013 Jul 1;99(1):203-214. doi: 10.1093/cvr/cvt103

Varkevisser R, Houtman MJC, Linder T, de Git KCG, Beekman HDM, Tidwell RR et al. Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue. British Journal of Pharmacology. 2013 Jul;169(6):1322-1334. doi: 10.1111/bph.12208

Garg V, Stary-Weinzinger A, Sanguinetti MC. ICA-105574 interacts with a common binding site to elicit opposite effects on inactivation gating of EAG and ERG potassium channels. Molecular Pharmacology. 2013 Apr;83(4):805-813. doi: 10.1124/mol.112.084384

Saxena P, Erker T, Bauer F, Weinzinger A, Linder T, Hering S et al. Drug Trapping in hERG Channels does not Require Closure of the Activation Gate. Biophysical Journal. 2013 Jan 29;104(2):266A-266A.

Linder T, de Groot BL, Stary-Weinzinger A. Probing the energy landscape of activation gating of the bacterial potassium channel KcsA. PLoS Computational Biology. 2013;9(5):e1003058. doi: 10.1371/journal.pcbi.1003058

Beyl S, Depil K, Hohaus A, Weinzinger A, Linder T, Timin E et al. Neutralisation of a single voltage sensor affects gating determinants in all four pore-forming S6 segments of Ca(V)1.2: a cooperative gating model. Pflügers Archiv: European Journal of Physiology. 2012 Oct;464(4):391-401. doi: 10.1007/s00424-012-1144-5

Ke S, Zangerl EM, Weinzinger A. Distinct interactions of Na(+) and Ca(2+) ions with the selectivity filter of the bacterial sodium channel Na(V)Ab. Biochemical and Biophysical Research Communications. 2012;430(4):1272-1276. doi: 10.1016/j.bbrc.2012.12.055

Jansen SA, Kleerekooper I, Hofman ZLM, Kappen IFPM, Weinzinger A, van der Heyden MAG. Grayanotoxin Poisoning: 'Mad Honey Disease' and Beyond. Cardiovascular Toxicology. 2012;12(3):208-215. doi: 10.1007/s12012-012-9162-2

Phillips S, Brammer AE, Rodriguez L, Lim HH, Weinzinger A, Matulef K. Surprises from an Unusual CLC Homolog. Biophysical Journal. 2012;103(9):44-46. doi: 10.1016/j.bpj.2012.08.063

Boukharta L, Keranen H, Weinzinger A, Wallin G, De Groot B, Aqvist J. Computer simulations of structure-activity relationships for HERG channel blockers. Biochemistry. 2011;50(27):6146-6156. doi: 10.1021/bi200173n


Garg V, Weinzinger A, Sachse F, Sanguinetti MC. Molecular Determinants for Activation of Human Ether-a-go-go-related Gene 1 Potassium Channels by 3-Nitro-N-(4-phenoxyphenyl) Benzamide. Molecular Pharmacology. 2011;80(4):630-637. doi: 10.1124/mol.111.073809


Beyl S, Depil K, Hohaus A, Weinzinger A, Timin E, Shabbir W et al. Physicochemical properties of pore residues predict activation gating of Ca(V)1.2: A correlation mutation analysis. Pflügers Archiv: European Journal of Physiology. 2011;461(1):53-63. doi: 10.1007/s00424-010-0885-2

Depil K, Beyl S, Weinzinger A, Hohaus A, Timin E, Hering S. Timothy mutation disrupts the link between activation and inactivation in Ca(V)1.2 protein. Journal of Biological Chemistry. 2011;286(36):31557-31564. doi: 10.1074/jbc.M111.255273

41 - 60 out of 72

Allosteric control of GIRK channels: insights from channelopathies and drug modulation

Weinzinger, A. (Speaker)

Mar 2026

Activity: Talks and presentationsTalk or oral contributionScience to Science


Ion Channels in Health and Disease: From Mechanistic Understanding to Therapeutic Solutions

Weinzinger, A. (Speaker)

16 Sept 2025

Activity: Talks and presentationsTalk or oral contributionScience to Science


GNB1: Mutations, Protein Interactions, and Drug Repurposing

Weinzinger, A. (Speaker)

24 Jun 2025

Activity: Talks and presentationsTalk or oral contributionScience to Public


GIRK2 DRUG REPURPOSING SCREEN IDENTIFIES TREATMENT OPTIONS FOR PATIENTS SUFFERING FROM EXTREMELY RARE DISEASES

Netzer, M. (Speaker), Hering, S. (Contributor), Dascal, N. (Contributor) & Weinzinger, A. (Contributor)

16 Feb 2025

Activity: Talks and presentationsTalk or oral contributionScience to Science


Allosteric mechanisms of inward rectifier K+ channel gating probed by disease mutants and ethosuximide

Weinzinger, A. (Speaker)

12 Sept 2024

Activity: Talks and presentationsTalk or oral contributionScience to Science


Allosteric regulation of GIRK K+ channels

Weinzinger, A. (Speaker)

9 Jul 2024

Activity: Talks and presentationsTalk or oral contributionScience to Science


Allosteric mechanisms of inward rectifier K+ channel gating

Weinzinger, A. (Speaker)

23 Jun 2024

Activity: Talks and presentationsTalk or oral contributionScience to Science


Challenges in drug repurposing for rare diseases – the GNB1/KCNJ6 example

Weinzinger, A. (Speaker)

12 Sept 2023

Activity: Talks and presentationsTalk or oral contributionScience to Science


Probing Inward Rectifier K+ Channel Gating and Conductance Guided by Disease Mutations

Weinzinger, A. (Speaker)

21 Jun 2023

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational investigation of a rare disease

Friesacher, T. (Speaker) & Weinzinger, A. (Contributor)

Sept 2022 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


Visualizing individual protonation events in Kir2 channels

Jirout, M. (Speaker), Zangerl-Plessl, E. M. (Contributor) & Weinzinger, A. (Contributor)

Sept 2022 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational investigations of ion channels

Weinzinger, A. (Speaker)

15 Sept 201920 Sept 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


FASEB: The Ion Channel Regulation Conference: Molecules to Disease

Weinzinger, A. (Speaker)

7 Jul 201912 Jul 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


Structure-dynamics-function relationships of inward rectifier K+ channels probed by in silico methods

Weinzinger, A. (Speaker)

27 Mar 2018

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational investigations of cation channels

Weinzinger, A. (Speaker)

19 May 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico modelling and drug interactions in Kir6.1

Weinzinger, A. (Speaker)

4 Oct 2016

Activity: Talks and presentationsTalk or oral contributionOther


Molecular modeling of Cantu Syndrome Channels

Weinzinger, A. (Speaker)

10 Sept 2015

Activity: Talks and presentationsTalk or oral contributionOther


Computational investigations of hERG K+ channels

Weinzinger, A. (Speaker)

10 Aug 2015

Activity: Talks and presentationsTalk or oral contributionOther


MD SIMULATIONS OF KIRBAC1.1 MUTANTS REVEAL GATING CHANGES AT THE BUNDLE CROSSING REGION

Weinzinger, A. (Speaker)

4 Feb 2013

Activity: Talks and presentationsTalk or oral contributionOther


Investigating the structural basis of hERG channel block guided by molecular dynamics simulations

Weinzinger, A. (Speaker)

25 Sept 2012

Activity: Talks and presentationsTalk or oral contributionOther


In silico modelling of Kir2.x channels

Weinzinger, A. (Speaker)

2011 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


IK1 block by small molecules

Weinzinger, A. (Speaker)

2010 → …

Activity: Talks and presentationsTalk or oral contributionOther


In silico prediction of the cardiotoxicity of drug candidates

Weinzinger, A. (Speaker)

2008 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


Modelling the hERG K+ channel

Weinzinger, A. (Speaker)

2008 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


Towards a consensus model of the hERG K+ channel

Weinzinger, A. (Speaker)

2008 → …

Activity: Talks and presentationsTalk or oral contributionOther


Computer modeling strategies to investigate the molecular basis of odor discrimination

Weinzinger, A. (Speaker)

2006 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


Novel approaches to investigate the regulation of G-protein coupled inward rectifier K+ channels by Gβγ

Weinzinger, A. (Project Lead) & Friesacher, T. (Co-Lead)

1/08/2131/07/24

Project: Research funding


PROSTAGLANDINES - POTENTIAL THERAPEUTICS FOR DEND SYNDROME?

Weinzinger, A. (Project Lead)

1/12/2030/07/23

Project: Research funding


Sulfonylharnstoffe

Weinzinger, A. (Project Lead)

1/03/1528/02/19

Project: Research funding


hERG K+ Channel activators

Weinzinger, A. (Project Lead)

4/11/144/11/15

Project: Research funding


hEAG1 channel blockers

Weinzinger, A. (Project Lead)

15/03/1414/03/15

Project: Research funding


Molecular Drug Targets

Hering, S. (Project Lead), Ecker, G. (Co-Lead), Maulide, N. (Co-Lead), Weinzinger, A. (Co-Lead) & Gonzalez Herrero, L. (Co-Lead)

1/12/1031/12/22

Project: Research funding


hERG potassium channel

Weinzinger, A. (Project Lead)

27/10/1031/12/11

Project: Research funding


Department of Pharmaceutical Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2D178

T: +43-1-4277-55311

anna.stary@univie.ac.at